Global Genomics In Cancer Care Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 27-Jul-2020
No. of pages: 130
Inquire Before Buying

Genomics In Cancer Care market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

- Illumina

- Thermo Fisher scientific

- Agilent

- Roche

- Cancer Genetics

- Beckman Coulter

- Bio-Rad

- Danaher

- Sigma Aldrich

- Pacific Biosciences

- Quest Diagnostics

- Luminex

- Oxford Gene Technology

- PerkinElmer

- Qiagen

- GE Healthcare

- Thermo Fisher scientific

Market segment by Type, the product can be split into

- Instruments

- Consumables

- Services

Market segment by Application, split into

- Diagnostics

- Personalized Medicine

- Drug Discovery

- Development

- Research

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

Global Genomics In Cancer Care Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
1.4 Market by Type
1.4.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.4.4 Services
1.5 Market by Application
1.5.1 Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Personalized Medicine
1.5.4 Drug Discovery
1.5.5 Development
1.5.6 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2015-2026)
2.2 Global Genomics In Cancer Care Growth Trends by Regions
2.2.1 Genomics In Cancer Care Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2015-2020)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Genomics In Cancer Care Market Growth Strategy
2.3.6 Primary Interviews with Key Genomics In Cancer Care Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Market Size
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2015-2020)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2015-2020)
3.1.3 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomics In Cancer Care Market Concentration Ratio
3.2.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2019
3.3 Genomics In Cancer Care Key Players Head office and Area Served
3.4 Key Players Genomics In Cancer Care Product Solution and Service
3.5 Date of Enter into Genomics In Cancer Care Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2015-2020)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Genomics In Cancer Care Market Size by Application (2015-2020)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2015-2020)
6.2 Genomics In Cancer Care Key Players in North America (2019-2020)
6.3 North America Genomics In Cancer Care Market Size by Type (2015-2020)
6.4 North America Genomics In Cancer Care Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2015-2020)
7.2 Genomics In Cancer Care Key Players in Europe (2019-2020)
7.3 Europe Genomics In Cancer Care Market Size by Type (2015-2020)
7.4 Europe Genomics In Cancer Care Market Size by Application (2015-2020)
8 China
8.1 China Genomics In Cancer Care Market Size (2015-2020)
8.2 Genomics In Cancer Care Key Players in China (2019-2020)
8.3 China Genomics In Cancer Care Market Size by Type (2015-2020)
8.4 China Genomics In Cancer Care Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genomics In Cancer Care Market Size (2015-2020)
9.2 Genomics In Cancer Care Key Players in Japan (2019-2020)
9.3 Japan Genomics In Cancer Care Market Size by Type (2015-2020)
9.4 Japan Genomics In Cancer Care Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genomics In Cancer Care Market Size (2015-2020)
10.2 Genomics In Cancer Care Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020)
10.4 Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020)
11 India
11.1 India Genomics In Cancer Care Market Size (2015-2020)
11.2 Genomics In Cancer Care Key Players in India (2019-2020)
11.3 India Genomics In Cancer Care Market Size by Type (2015-2020)
11.4 India Genomics In Cancer Care Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genomics In Cancer Care Market Size (2015-2020)
12.2 Genomics In Cancer Care Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomics In Cancer Care Market Size by Type (2015-2020)
12.4 Central & South America Genomics In Cancer Care Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview
13.1.3 Illumina Genomics In Cancer Care Introduction
13.1.4 Illumina Revenue in Genomics In Cancer Care Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Thermo Fisher scientific
13.2.1 Thermo Fisher scientific Company Details
13.2.2 Thermo Fisher scientific Business Overview
13.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
13.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
13.2.5 Thermo Fisher scientific Recent Development
13.3 Agilent
13.3.1 Agilent Company Details
13.3.2 Agilent Business Overview
13.3.3 Agilent Genomics In Cancer Care Introduction
13.3.4 Agilent Revenue in Genomics In Cancer Care Business (2015-2020)
13.3.5 Agilent Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Genomics In Cancer Care Introduction
13.4.4 Roche Revenue in Genomics In Cancer Care Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Cancer Genetics
13.5.1 Cancer Genetics Company Details
13.5.2 Cancer Genetics Business Overview
13.5.3 Cancer Genetics Genomics In Cancer Care Introduction
13.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020)
13.5.5 Cancer Genetics Recent Development
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Details
13.6.2 Beckman Coulter Business Overview
13.6.3 Beckman Coulter Genomics In Cancer Care Introduction
13.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020)
13.6.5 Beckman Coulter Recent Development
13.7 Bio-Rad
13.7.1 Bio-Rad Company Details
13.7.2 Bio-Rad Business Overview
13.7.3 Bio-Rad Genomics In Cancer Care Introduction
13.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020)
13.7.5 Bio-Rad Recent Development
13.8 Danaher
13.8.1 Danaher Company Details
13.8.2 Danaher Business Overview
13.8.3 Danaher Genomics In Cancer Care Introduction
13.8.4 Danaher Revenue in Genomics In Cancer Care Business (2015-2020)
13.8.5 Danaher Recent Development
13.9 Sigma Aldrich
13.9.1 Sigma Aldrich Company Details
13.9.2 Sigma Aldrich Business Overview
13.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
13.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020)
13.9.5 Sigma Aldrich Recent Development
13.10 Pacific Biosciences
13.10.1 Pacific Biosciences Company Details
13.10.2 Pacific Biosciences Business Overview
13.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
13.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020)
13.10.5 Pacific Biosciences Recent Development
13.11 Quest Diagnostics
10.11.1 Quest Diagnostics Company Details
10.11.2 Quest Diagnostics Business Overview
10.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
10.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020)
10.11.5 Quest Diagnostics Recent Development
13.12 Luminex
10.12.1 Luminex Company Details
10.12.2 Luminex Business Overview
10.12.3 Luminex Genomics In Cancer Care Introduction
10.12.4 Luminex Revenue in Genomics In Cancer Care Business (2015-2020)
10.12.5 Luminex Recent Development
13.13 Oxford Gene Technology
10.13.1 Oxford Gene Technology Company Details
10.13.2 Oxford Gene Technology Business Overview
10.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
10.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020)
10.13.5 Oxford Gene Technology Recent Development
13.14 PerkinElmer
10.14.1 PerkinElmer Company Details
10.14.2 PerkinElmer Business Overview
10.14.3 PerkinElmer Genomics In Cancer Care Introduction
10.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020)
10.14.5 PerkinElmer Recent Development
13.15 Qiagen
10.15.1 Qiagen Company Details
10.15.2 Qiagen Business Overview
10.15.3 Qiagen Genomics In Cancer Care Introduction
10.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2015-2020)
10.15.5 Qiagen Recent Development
13.16 GE Healthcare
10.16.1 GE Healthcare Company Details
10.16.2 GE Healthcare Business Overview
10.16.3 GE Healthcare Genomics In Cancer Care Introduction
10.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020)
10.16.5 GE Healthcare Recent Development
13.17 Thermo Fisher scientific
10.17.1 Thermo Fisher scientific Company Details
10.17.2 Thermo Fisher scientific Business Overview
10.17.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
10.17.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
10.17.5 Thermo Fisher scientific Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Genomics In Cancer Care Key Market Segments
Table 2. Key Players Covered: Ranking by Genomics In Cancer Care Revenue
Table 3. Ranking of Global Top Genomics In Cancer Care Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instruments
Table 6. Key Players of Consumables
Table 7. Key Players of Services
Table 8. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Genomics In Cancer Care Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Genomics In Cancer Care Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Genomics In Cancer Care Market Share by Regions (2015-2020)
Table 12. Global Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Genomics In Cancer Care Market Growth Strategy
Table 18. Main Points Interviewed from Key Genomics In Cancer Care Players
Table 19. Global Genomics In Cancer Care Revenue by Players (2015-2020) (Million US$)
Table 20. Global Genomics In Cancer Care Market Share by Players (2015-2020)
Table 21. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019)
Table 22. Global Genomics In Cancer Care by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Genomics In Cancer Care Product Solution and Service
Table 25. Date of Enter into Genomics In Cancer Care Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 28. Global Genomics In Cancer Care Market Size Share by Type (2015-2020)
Table 29. Global Genomics In Cancer Care Revenue Market Share by Type (2021-2026)
Table 30. Global Genomics In Cancer Care Market Size Share by Application (2015-2020)
Table 31. Global Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 32. Global Genomics In Cancer Care Market Size Share by Application (2021-2026)
Table 33. North America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 35. North America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 36. North America Genomics In Cancer Care Market Share by Type (2015-2020)
Table 37. North America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 38. North America Genomics In Cancer Care Market Share by Application (2015-2020)
Table 39. Europe Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 41. Europe Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Genomics In Cancer Care Market Share by Type (2015-2020)
Table 43. Europe Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Genomics In Cancer Care Market Share by Application (2015-2020)
Table 45. China Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 46. China Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 47. China Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 48. China Genomics In Cancer Care Market Share by Type (2015-2020)
Table 49. China Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 50. China Genomics In Cancer Care Market Share by Application (2015-2020)
Table 51. Japan Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 53. Japan Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Genomics In Cancer Care Market Share by Type (2015-2020)
Table 55. Japan Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Genomics In Cancer Care Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 59. Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Genomics In Cancer Care Market Share by Type (2015-2020)
Table 61. Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Genomics In Cancer Care Market Share by Application (2015-2020)
Table 63. India Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 64. India Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 65. India Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 66. India Genomics In Cancer Care Market Share by Type (2015-2020)
Table 67. India Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 68. India Genomics In Cancer Care Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Genomics In Cancer Care Market Share (2019-2020)
Table 71. Central & South America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Genomics In Cancer Care Market Share by Type (2015-2020)
Table 73. Central & South America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Genomics In Cancer Care Market Share by Application (2015-2020)
Table 75. Illumina Company Details
Table 76. Illumina Business Overview
Table 77. Illumina Product
Table 78. Illumina Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 79. Illumina Recent Development
Table 80. Thermo Fisher scientific Company Details
Table 81. Thermo Fisher scientific Business Overview
Table 82. Thermo Fisher scientific Product
Table 83. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 84. Thermo Fisher scientific Recent Development
Table 85. Agilent Company Details
Table 86. Agilent Business Overview
Table 87. Agilent Product
Table 88. Agilent Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 89. Agilent Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Cancer Genetics Company Details
Table 96. Cancer Genetics Business Overview
Table 97. Cancer Genetics Product
Table 98. Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 99. Cancer Genetics Recent Development
Table 100. Beckman Coulter Company Details
Table 101. Beckman Coulter Business Overview
Table 102. Beckman Coulter Product
Table 103. Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 104. Beckman Coulter Recent Development
Table 105. Bio-Rad Company Details
Table 106. Bio-Rad Business Overview
Table 107. Bio-Rad Product
Table 108. Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 109. Bio-Rad Recent Development
Table 110. Danaher Business Overview
Table 111. Danaher Product
Table 112. Danaher Company Details
Table 113. Danaher Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 114. Danaher Recent Development
Table 115. Sigma Aldrich Company Details
Table 116. Sigma Aldrich Business Overview
Table 117. Sigma Aldrich Product
Table 118. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 119. Sigma Aldrich Recent Development
Table 120. Pacific Biosciences Company Details
Table 121. Pacific Biosciences Business Overview
Table 122. Pacific Biosciences Product
Table 123. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 124. Pacific Biosciences Recent Development
Table 125. Quest Diagnostics Company Details
Table 126. Quest Diagnostics Business Overview
Table 127. Quest Diagnostics Product
Table 128. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 129. Quest Diagnostics Recent Development
Table 130. Luminex Company Details
Table 131. Luminex Business Overview
Table 132. Luminex Product
Table 133. Luminex Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 134. Luminex Recent Development
Table 135. Oxford Gene Technology Company Details
Table 136. Oxford Gene Technology Business Overview
Table 137. Oxford Gene Technology Product
Table 138. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 139. Oxford Gene Technology Recent Development
Table 140. PerkinElmer Company Details
Table 141. PerkinElmer Business Overview
Table 142. PerkinElmer Product
Table 143. PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 144. PerkinElmer Recent Development
Table 145. Qiagen Company Details
Table 146. Qiagen Business Overview
Table 147. Qiagen Product
Table 148. Qiagen Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 149. Qiagen Recent Development
Table 150. GE Healthcare Company Details
Table 151. GE Healthcare Business Overview
Table 152. GE Healthcare Product
Table 153. GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 154. GE Healthcare Recent Development
Table 155. Thermo Fisher scientific Company Details
Table 156. Thermo Fisher scientific Business Overview
Table 157. Thermo Fisher scientific Product
Table 158. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
Table 159. Thermo Fisher scientific Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
Figure 6. Diagnostics Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Development Case Studies
Figure 10. Research Case Studies
Figure 11. Genomics In Cancer Care Report Years Considered
Figure 12. Global Genomics In Cancer Care Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Genomics In Cancer Care Market Share by Regions: 2020 VS 2026
Figure 14. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Genomics In Cancer Care Market Share by Players in 2019
Figure 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2019
Figure 19. North America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
  • Global Agrigenomics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 87
    Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology. The global Agrigenomics market was valued at US$ 4849.2 million in 2023 and is anticipated to reach US$ 7524.5 million by 2030, witnessing a CAGR of 6.4% during The forecast period 2024-2030. Thermo Fisher Scientific,......
  • Global Agrigenomics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Agrigenomics market size was valued at US$ 4743.7 million in 2023. With growing demand in downstream market, the Agrigenomics is forecast to a readjusted size of US$ 7439.4 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Agrigenomics market. Agrigenomics are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Agrigenomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Agrigenomics market size was valued at USD 4989.6 million in 2023 and is forecast to a readjusted size of USD 7564.5 million by 2030 with a CAGR of 6.1% during review period. Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other t......
  • Global Gene Editing Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Merck - Horizo??n Discovery - Sangamo BioSciences - Integrated DNA Technologies - Lonza - New England Biolabs - ......
  • Global Agrigenomics Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 101
    Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......
  • Global Agrigenomics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Agrigenomics market: According to our latest research, the global Agrigenomics market looks promising in the next 5 years. As of 2022, the global Agrigenomics market was estimated at USD 5139.47 million, and it's anticipated to reach USD 7676.54 million in 2028, with a CAGR of 6.92% during the forecast years. Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce. Application of genomics ......
  • Global Agrigenomics Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......
  • Global Genomics in Cancer Care Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Genomics in Cancer Care market: According to our latest research, the global Genomics in Cancer Care market looks promising in the next 5 years. As of 2022, the global Genomics in Cancer Care market was estimated at USD 4369.0 million, and it's anticipated to reach USD 11429.15 million in 2028, with a CAGR of 17.38% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Gene Editing Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 200
    Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs